Foundation studies digital health’s impact on outcomes for COPD patients
By HME News Staff
Updated 9:07 AM CST, Mon January 10, 2022
NEW HAVEN, Conn. – The COPD Foundation, a patient advocacy and research organization, and Wellinks, a digital health care company that offers an integrated, virtual COPD disease management solution, have partnered to recruit eligible patients for a new study through the foundation’s COPD Patient-Powered Research Network. Researchers plan to enroll between 100 and 150 adults with COPD for a 24-week prospective research study of the Wellinks solution. “We are passionate about ensuring that people with COPD have access to the best treatment options available,” said Ruth Tal-Singer, PhD, president and chief scientific officer of the COPD Foundation. “We are excited to use our COPD PPRN to recruit individuals to assess this novel COPD management program. Especially after COVID-19, the Wellinks platform could be impactful in helping patients manage their health, and we look forward to learning more through this study.” Wellinks combines virtual pulmonary rehabilitation, personalized health coaching and a patient-friendly app to access monitoring through connected devices. The study aims to determine whether Wellinks can improve outcomes for patients with COPD by measuring the impact on health-related quality of life, health care resource utilization and patient satisfaction. Researchers will assess impact alongside additional measures, such as pulmonary function and symptoms.
Comments